Oliver Eckelmann

Leadership Team

Oliver Eckelmann, COO & CFO

Since mid-2019 he serves as the COO and CFO of Light Chain Bioscience – NovImmune SA.

Oliver joined the Pharmaceutical company Roche in the beginning of 2006 and has held positions of increasing responsibility in controlling and planning. In 2009 he was appointed as Roche’s VP/Global Head of Strategy, Planning and Special Projects in Basel, Switzerland. In September 2012 he took over the role as CFO and Deputy CEO for Roche in Australia.

At the beginning of his career, he has held positions with consultancy firms Booz & company and Roland Berger Strategy Consultants.

Oliver holds a PhD in economics.

Back

First patient dosed with NILK-2301 in Phase I clinical trial

First-in-human trial of a CEACAM5xCD3 bispecific κλ body for solid cancer


Read more

LinkedIn